Data that Can Change TAVR and SAVR Strategy

In many relatively young patients with severe aortic stenosis, we rule out the idea of a mechanical valve, opting for a surgical aortic valve replacement (SAVR) with a bioprosthesis; we bet once the surgical bioprosthesis deteriorates, we will be able to solve it with transcatheter aortic valve replacement (TAVR) of the failed surgical valve: TAV-in-SAV. 

Datos que pueden cambiar la estrategia del TAVI y la cirugía

Data of this study recently published in JACC might challenge this idea. Technically speaking, treating a dysfunctional TAVR with redo TAVR (TAV-in-TAV) seems a lot simpler than treating a dysfunctional surgical valve with TAVR, with similar safety and mortality rates. 

These data support a new strategy: doing TAVR right from the start.  This idea stems from evidence on low risk, younger patients at long term follow up. When the valve deteriorates, we can redo TAVR.

Data from 434 patients undergoing TAV-in-TAV were compared against data from 624 undergoing TAV-in-SAV included in the multicenter registry Redo-TAVR international. Populations were matched using propensity score, leaving 165 patients with similar characteristics in each branch. 


Read also: Predilation in TAVR and Myocardial Injury.


Primary end point was procedural success, safety and mortality at 30 days and one year. 

TAV-in-TAV procedural success was achieved in 72.7% of patients vs 62.4% in TAV-in-SAV. This advantage of TAV-in-TAV was conducted by lower frequency of residual high valve gradient (p = 0.095), ectopic valve deployment (p = 0.081), coronary obstruction (p = 0.091), and conversion to open heart surgery (p=0.082).

Procedural safety was achieved in 70.3% of TAV-in-TAV vs. 72.1% TAV-in-SAV (p=0.715).

Mortality at 30 days resulted similar (3% vs 4.4%, p=0.57 respectively), as was mortality at one year (11.9% vs 10.2%, p=0.633). 


Read also: Diastolic Dysfunction and TAVR: Prognosis before and after Procedure.


The resulting valvular area was larger (1.55 ± 0.5 cm2 vs. 1.37 ± 0.5 cm2; p=0.040) and mean residual gradient was lower (12.6 ± 5.2 mm Hg vs. 14.9 ± 5.2 mm Hg; p=0.011) with TAV-in-TAV.

Moderate to severe aortic regurgitation was similar but mild regurgitation was more frequent with TAV-in-TAV (p=0.003).

Conclusion

This study comparing populations undergoing TAV-in-TAV vs TAV-in-SAV using propensity score matching showed similar safety and mortality but higher procedural success with TAV-in-TAV. 

j-jacc-2020-10-053free

Original Title: Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses.

Reference: Uri Landes et al. J Am Coll Cardiol 2021;77:1–14 https://doi.org/10.1016/j.jacc.2020.10.053.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...